Phar­ma IP in view as new USP­TO di­rec­tor Kathi Vi­dal wins Sen­ate con­fir­ma­tion

The US Patent and Trade­mark Of­fice (USP­TO) has a new Sen­ate-con­firmed di­rec­tor who may take a crack at phar­ma patents, as the spot­light has cen­tered on them through­out the pan­dem­ic.

Pres­i­dent Biden’s nom­i­nee Kathi Vi­dal, con­firmed via voice vote on Tues­day night, will take the reins of USP­TO’s 13,000+ em­ploy­ees and its near­ly $4 bil­lion bud­get, af­ter she served as man­ag­ing part­ner of Win­ston & Strawn’s Sil­i­con Val­ley of­fice, af­ter serv­ing for more than 25 years as an IP lit­i­ga­tor in pri­vate prac­tice.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER